Abstract
Emodic acid (1) and 6-chloroemodic acid (2) have been identified from a natural product database as useful scaffolds for the future development of novel JAK2 inhibitors using structure-based high-throughput virtual screening. Low-energy binding conformations of 1 and 2 in the JAK2 PTK domain were generated by virtual ligand docking and were found to overlap considerably with the binding pose of CMP6, a known JAK2 inhibitor. Compounds 1 and 2 displayed low micromolar efficacies against JAK2 enzyme activity and JAK2 autophosphorylation in human erythroleukemia cells, and inhibited STAT3 DNA-binding activity in a human hepatocarcinoma cell line.
Original language | English |
---|---|
Pages (from-to) | 21-25 |
Number of pages | 5 |
Journal | Methods |
Volume | 71 |
Issue number | C |
DOIs | |
Publication status | Published - 2015 |
Scopus Subject Areas
- Molecular Biology
- Biochemistry, Genetics and Molecular Biology(all)
User-Defined Keywords
- 6-Chloroemodic acid
- Emodic acid
- JAK2
- Natural product
- Virtual screening